Polyene Antifungal
Nilstat
The FDA lists this product in 6 strengths and forms.
Indications
Nystatin oral suspension is indicated for the treatment of infections of the oral cavity caused by Candida albicans .
Contraindications
Nystatin is contraindicated in patients with a history of hypersensitivity to nystatin or any of the suspension components.
Adverse reactions
Gastrointestinal symptoms including diarrhea, gastrointestinal distress, nausea, vomiting and burning of the mouth have been reported. Hypersensitivity reactions including rash, pruritus, and anaphylactoid reaction have also been reported.
Composition
- Active ingredients
- NYSTATIN 100,000 UNITS/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NYSTATIN 100% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · PowderNDA050576-001 · Discontinued
- NYSTATIN 500,000 UNITS · TabletANDA061151-001 · Discontinued
- NYSTATIN 100,000 UNITS/GM · CreamANDA061445-001 · Discontinued
- NYSTATIN 100,000 UNITS/GM · OintmentANDA061444-001 · Discontinued
- NYSTATIN 100,000 UNITS · TabletANDA061325-001 · Discontinued
- NYSTATIN 100,000 UNITS/ML · SuspensionThis page